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ABSTRACT
Introduction: The benefits of physical activity for people
with multiple sclerosis (pwMS) have been recognised.
However, exercise regimens can be difficult to maintain
over the longer term and pwMS may face unique barriers
to physical activity engagement. Pilot research suggests
the Nintendo Wii can be used safely at home by pwMS
with minimal mobility/balance issues and may confer
benefits. We have developed a home-based
physiotherapist supported Wii intervention (‘Mii-vitaliSe’)
for pwMS that uses commercial software. This is a pilot
study to explore the feasibility of conducting a full scale
clinical and cost-effectiveness trial of Mii-vitaliSe.
Methods and analysis: 30 ambulatory, relatively
inactive pwMS will be randomised to receive Mii-vitaliSe
immediately, or after 6 months. Outcomes, measured at
baseline and 6 and 12 months later, will include balance,
gait, mobility, hand dexterity and self-reported physical
activity levels, fatigue, self-efficacy, mood and quality of
life. Interviews conducted on a purposive sample of
participants will explore experiences of participation in the
study and barriers and facilitators to using the Wii. Mean
recruitment, adherence rate and standard deviations (SDs)
of potential primary outcomes for the full trial will be
estimated and precision summarised using 95%
confidence intervals (CIs). Interview transcripts will be
thematically analysed using a generic qualitative
approach.
Ethics and dissemination: National Health Service
(NHS; ref 12/SC/0420) and university ethical approvals
have been obtained as has NHS Research and
Development permission from the relevant trust. A home
risk assessment will be undertaken for all potential
participants. All adverse events will be closely monitored,
documented and reported to the study Safety Monitoring
Committee. At least one publication in a peer reviewed
journal will be produced and research findings presented
at a national and international conference. With service
users, we will coproduce a summary of the findings for
dissemination on our research unit’s website and
elsewhere.
Trial registration number: ISRCTN 49286846.
INTRODUCTION
Historically, people with multiple sclerosis
(pwMS) have been advised to limit physical
activity levels. However, over the last decade
the salutary effects of exercise for pwMS have
become evident,1–5 with no deleterious
effects described.1 6–9 Physical activity has
been shown to be associated with improve-
ments in mobility, muscle strength and phys-
ical ﬁtness.1 9–14 In a meta-analysis, planned
and structured regular exercise was asso-
ciated with a small improvement in quality of
life (QoL) in MS.15 Other secondary beneﬁts
might include reduced fatigue, depression
and anxiety and improved sense of well-
being—although more rigorous trials are
needed.14 16 Early intervention may help to
slow or prevent the accumulation of physical
disability.17 18
However, pwMS typically engage in dramat-
ically lower levels of physical activity than the
general population.2 4 19 This can lead to a
downward spiral of deconditioning, fatigue,
reduced self-efﬁcacy, increased levels of dis-
ability4 as well as increased health risks (such
as cardiovascular diseases, obesity, diabetes,
etc). Psychosocial repercussions include
reduced leisure, social contacts, role
Strengths and limitations of this study
▸ This pilot study will include a long-term (1 year)
follow-up to consider adherence.
▸ The intervention will incorporate individual tai-
loring, behavioural change strategies and home-
based Wii use with physiotherapist guidance.
▸ Mixed methods will be used.
▸ Physical outcome assessments will not be
blinded.
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fulﬁlment and engagement in activities of daily living;
all important for self-esteem and psychological
well-being.
People with long-term disabling conditions such as MS
face unique barriers to participation in physical activ-
ity20–28 including physical (eg, pain, fatigue, mobility lim-
itations and overheating), psychological (eg, fear,
embarrassment and lack of conﬁdence) and environ-
mental (transport, cost, lack of suitable facilities/trained
staff) factors. While home-based activities overcome
some of these, adherence to traditional exercise pro-
grammes is poor.29 Making exercise an enjoyable experi-
ence30–32 undertaken in a non-threatening and
comfortable environment along with the provision of
detailed guidance, monitoring and support may improve
adherence.2 30 32 33
The National Institute for Health and Care Excellence
(NICE) guidelines, the National Service Framework for
long-term conditions and the Health Foundation high-
light the importance of guided tailored self-
management supported by health professionals34–38 to
encourage engagement in physical activity and leisure
and social pursuits.
Physical activity is multifaceted and psychological
factors play a crucial role in its initiation and mainten-
ance. Adopting a multidisciplinary approach can help to
support behaviour change and physical activity prescrip-
tion. Social Cognitive Theory39 and in particular, the
concept of self-efﬁcacy40 41 has been proposed as a key
mediator in the promotion and maintenance of physical
activity42 43 and adherence32 44–46 and an important pre-
dictor of health status.47
The Wii overcomes some of the barriers to participa-
tion in physical activity highlighted earlier. It is low cost,
can be used at home, and has broad appeal, incorporat-
ing variables known to enhance motivation, self-
efﬁcacy48 and adherence (such as self-monitoring,
prompts, peer comparison and feedback about progress
and performance) in the context of fun49–52 purposeful
tasks.53 It offers opportunities for socialisation across the
lifespan54 55 and participation in immersive virtual
reality activities that might, in real life, be challenging
due to physical limitations, or require further adaptation
to enable participation (eg, golf). Games such as Wii
Sports use signiﬁcantly more energy than sedentary
activities56–60 (though not as much as playing the sport
itself).57 58
For the current study the Wii was deemed preferable
over other newer more complex virtual reality platforms,
such as the Xbox Kinect: it is low cost, requires less
space, permits support from a therapist within the ﬁeld
of view and the Wii sensors are relatively ‘forgiving’
thereby facilitating use by people with impaired or com-
promised movement.61 Our ﬁndings will, nevertheless,
have applicability to and relevance for other platforms
and chronic conditions.
In conjunction with the Wii balance board, the Wii Fit
Plus incorporates games requiring the user to shift his/her
weight from side to side and forwards and back to control
gameplay. A key feature of these systems is the provision of
dynamic visual feedback about centre of gravity allowing
training and adjustments of movement via biofeedback
techniques. These recent advances in interactive gaming
have created the potential for increasing physical activity
and decreasing sedentary behaviour.62 It has been sug-
gested that such games may be helpful for improving
balance and core strength63 under the guidance of a quali-
ﬁed health/rehabilitation professional (who can advise on
the selection of appropriate activities to challenge balance
safely and gradually).
Wii games can be played for brief periods, at the indi-
vidual’s convenience. Daily activity levels can be accumu-
lated in short bouts of 10 min or more throughout the
day (which is thought to be as effective as all in one
go43 64), at differing levels, and a range of activities can
be selected, depending on current symptoms65 and pre-
ferences. Creating a personalised representation of
oneself (a ‘Mii’) may enhance self-efﬁcacy via a greater
sense of ‘presence’ and motivation.66
However, there are potential disadvantages. As with
other physical activities, playing the Wii could lead to
injury, discomfort67 68 or increased symptoms. Many of
the reported injuries have been due to people exercising
beyond their limitations and without resting adequately.
The user manual69 provides guidance on how to use the
Wii safely and onscreen prompts about resting are regu-
larly provided. As the Wii software has been developed
with a healthy population in mind, it is important to
explore its acceptability to pwMS.70
While applications of the Wii are diverse71–82 and pre-
liminary ﬁndings positive, the evidence base is limited
and deﬁnitive answers require well-designed randomised
controlled trials (RCTs). In this pilot study, we wish to
explore whether a commercially available interactive
gaming system, the Nintendo Wii, offers a safe, feasible
way to provide opportunities in the home for increased
physical activity for pwMS (which could lead to improve-
ments in domains such as vitality, balance, mobility, QoL
and well-being). To date, Wii research with people
affected by MS is mostly preliminary. Early ﬁndings are
promising, however, and suggest that the Wii might be
helpful for balance83–85 and ﬁtness.86
In a non-randomised pilot study Plow and Finlayson,86
found that pwMS who have mild balance and mobility
limitations can use the Wii Fit safely at home. However,
they also reported that Wii use declined after 3 months.
They suggested that a more person-centred approach as
well as the use of behavioural change techniques (such
as motivational interviewing and problem solving) might
help to promote longer term Wii use and foster intrinsic
motivation. In a scoping review of the exergaming litera-
ture Plow et al87 recommended that trials incorporate
longer term follow-up periods, employ mixed methods
and follow patients from the clinical setting to the
home. Others have suggested that an individualised
approach is essential to take into account individuals’
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beliefs, self-efﬁcacy and perceptions about exercise31
and their self-identity, goals and expectations for improv-
ing health.70 88
Often research projects proceed rapidly to a full scale
RCT, with vital, preparatory phases overlooked.89 This
can result in a resource intensive and costly analysis of a
conceptually or clinically ﬂawed intervention. In this
study, we have consulted with pwMS already using the
Wii, and adapted existing guidance on using the Wii to
develop a home-based physiotherapist supported Wii
intervention for pwMS (Mii-vitaliSe). We will undertake
a small pilot RCT of the Mii-vitaliSe intervention to
explore the feasibility of a full-scale formal evaluation of
effectiveness.90
METHODS
Aim
To investigate the feasibility of conducting a multicentre
deﬁnitive RCT to assess the clinical and cost-
effectiveness of a home-based physiotherapist supported
Wii intervention (Mii-vitaliSe) for pwMS.
Objectives
1. Test procedures (including administration of the self-
reported outcomes and the physical assessments,
delivery of the intervention, recording and monitor-
ing of adverse events (AEs)), estimate recruitment
and retention rates, and reﬁne the selection of
outcome measures in preparation for a deﬁnitive
RCT to test the effectiveness of Mii-vitaliSe.
2. Collect data on the variability of outcome measures
to inform a sample size calculation for a larger trial.
3. Estimate adherence rates via a self-reported daily play
log (in terms of frequency, intensity, duration).
4. Determine the acceptability of randomisation and of
the Mii-vitaliSe intervention to participants and
obtain information about patterns of use/barriers to
use.
5. Gather feedback from physiotherapists about their
experiences of delivering Mii-vitaliSe.
Study design
A single centre wait-list controlled pilot study of
Mii-vitaliSe plus usual care versus usual care alone (see
ﬁgure 1) will be undertaken. Participants will be rando-
mised to receive Mii-vitaliSe immediately or after
6 months (‘delayed’ group). The delayed group will con-
tinue their usual routines and receive the Mii-vitaliSe
intervention after a 6-month delay. During this period,
they will be asked to refrain from using the Wii and will
act as controls for the immediate group.
This design has the potential to minimise the impact of
disappointment that those allocated to a non-
intervention group might experience, while ensuring
those in the delayed group receive the full intervention
with an emphasis on safety aspects. Delivering the inter-
vention to those in the delayed group may increase
compliance with refraining from use for a 6-month
period. This design also permits a preliminary consider-
ation of long-term (1 year) follow-up (immediate group
only). The randomised controlled component allows
testing of procedures, design, etc in preparation for a full
scale trial. Follow-up periods are sufﬁcient for novelty
value to diminish and patterns of use to be established.
Service user involvement
Following INVOLVE principles,91 services users have
been involved in all stages of the research so far, includ-
ing the development of this protocol. A service user con-
sultation was held to inform the content and format of
the Mii-vitaliSe materials and aspects of the study design.
Service users will be represented on the trial steering
group and will continue to provide ongoing input into
the study.
Data protection and data storage
All information collected during the course of the study
will be kept strictly conﬁdential and any information
that leaves Poole Hospital/Bournemouth University will
Figure 1 Mii-vitaliSe study flow chart.
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contain no personal details. Questionnaires will be allo-
cated a participant ID; they will not contain names or
any identifying details. Only authorised members of the
research team will have access to the study data.
Data will be collected and retained in accordance with
the Data Protection Act 1998. Study documents (paper
and electronic) will be retained in a secure location
during and after the trial has ﬁnished. All source docu-
ments will be retained for a period of 5 years following
the end of the study.
Compliance
The Chief Investigator will ensure that the study is con-
ducted in compliance with the principles of the
Declaration of Helsinki (1996) and in accordance with
all applicable regulatory requirements including, but
not limited to, the Research Governance Framework
and Trust policies and any subsequent amendments.
Sample size considerations
A ‘rule of thumb’ of 30 is common for pilot studies.92 A
sample size of 30 (15 in the immediate and 15 in the
delayed arm) will be adequate given the speciﬁc quanti-
tative aims of this pilot.
Objective 1 is to estimate the recruitment rate to help
in planning recruitment for a full scale RCT. Precision
of this estimate will be based on the width of the 95%
CI. With a total sample size of 30 people recruited, the
recruitment rate will be estimated with a precision of
±11% (assuming a recruitment rate of approximately
40% based on experiences of running a RCT of a
fatigue management programme for pwMS93).
Objective 2 is to estimate the SD of potential primary
outcome measures in preparation for a formal sample
size calculation for a larger RCT. Assuming these out-
comes are standardised, so that they have a SD of 1, the
precision (as summarised by standard error) will be
0.13. When using this estimate for a later sample size cal-
culation it will be inﬂated as suggested by Browne.94
Estimating the effect size for the Mii-vitaliSe intervention
is not an aim of this pilot, but would be the aim of a
later full scale RCT.
Objective 3 is to estimate the degree of adherence of
participants to Mii-vitaliSe. For each individual this will
be summarised as the number of days on which activities
were performed divided by the number of days agreed
with the physiotherapist in their action plan. The poten-
tial range is 0–1, and the SD will be at most 0.17
(NQuery Advisor). With a sample size of 30, average
adherence will be estimated with precision ±0.06 (ie,
width of 95% CI).
Participants
Thirty ‘inactive’ (see eligibility criteria) pwMS aged 18
or over, will be recruited from the Dorset MS Service.
Individuals excluded from the research project will con-
tinue to be seen as per usual care.
Eligibility criteria
Inclusion criteria
▸ Clinically deﬁnite diagnosis of MS
▸ Aged 18 or above
▸ Fulﬁl home risk assessment criteria (see below)
▸ ‘Inactive’ (physically active on fewer than 5 days/
week for ≥30 min)
▸ Living within Poole/Bournemouth conurbations
▸ Suitable television
Exclusion criteria
▸ Have only mild symptoms (equivalent to an Adapted
Patient Determined Disease Steps (APDDS) Scale95
score of 1) or require at least intermittent or unilat-
eral constant assistance (cane, crutch or brace) to
walk 100 m with or without resting (equivalent to an
Expanded Disability Status Scale (EDSS) score96 of 6
or more)
▸ Relapse within the past 3 months requiring
corticosteroids
▸ Already participating in exercise/rehabilitation
research
▸ Any medical condition placing participant at risk
from exercise participation/using Wii
▸ Owns a Wii and uses it regularly (weekly or more)
▸ Unwilling/unable to comply with protocol
Risk assessment
This will be undertaken at home by the study researcher
(who is a senior physiotherapist) to assess balance on
the Wii balance board and the suitability of the home
environment for setting up the equipment and using
the Wii.
Participants will be considered eligible if:
▸ They can maintain independent standing balance
with eyes open for 1 min.
▸ The physiotherapist clinically judges that they demon-
strate adequate balance reactions while on the Wii
balance board97 and are able to step off safely for-
wards, backwards and sideways.
▸ Their home environment is suitable (with minor
modiﬁcations, if appropriate and possible).
Identification and recruitment
Recruitment will be via the Dorset MS Service. Potential
participants will be identiﬁed by the multidisciplinary
Dorset MS team. A member of the MS team will go
through a screening checklist to identify potential parti-
cipants and will then either send or give them an invita-
tion letter with a simple one-page summary (‘Key Facts’)
about the study, participant information sheets, the
APDDS Scale, a question about current levels of physical
activity and a reply slip and pre-paid return envelope.
Participants will be asked to return the reply slip and
their responses if they wish to ﬁnd out more about the
study. A follow-up reminder letter with another copy of
the information pack will be sent if a reply is not
received within 2 weeks.
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Screening procedure
The study researcher will telephone those who have
expressed an interest in the research, describe the study in
more detail, answer questions and go through the remain-
ing screening criteria (see section ‘Exclusion criteria’) over
the telephone. Those not eligible will be informed over the
telephone. Individuals who fulﬁl the study criteria will be
visited at home for the risk and home suitability assess-
ment. Minor modiﬁcations to the home environment to
facilitate the safe use of the Wii balance board will be dis-
cussed with the potential participant and documented.
Individuals not eligible to take part will continue to be
seen as per usual care.
Informed consent process
Informed consent will be taken by the Good Clinical
Practice (GCP) accredited study researcher in indivi-
duals’ homes, providing they satisfy the risk and home
assessment criteria.
Randomisation
To ensure good allocation concealment, random alloca-
tion will be email based and administered by the study
statistician. Randomisation will be carried out on a 1:1
basis and will utilise a computer-based random sequence
generator. Variable-sized blocks will be used to ensure
approximately equal numbers in the two trial arms. No
stratiﬁcation will be used.
Outcome measures
As this is feasibility work, a broad range of outcomes has
been included. Participants will be requested to com-
plete the outcomes even if they stop using the Wii. A
detailed description of outcome measures is included in
the web supplement.
Outcomes will be assessed at baseline and at 6 and
12 months. Physical assessments (administered at similar
times of the day to reduce the confounding effect of
fatigue98) will be undertaken at the hospital by the study
researcher and a clinical scientist. Self-reported question-
naires (presented in a large font) will be completed by
participants in their homes, at their own convenience and
pace.
Demographic/descriptor variables
Age, sex, education, employment, marital status, ethni-
city, household composition, time since diagnosis, disease
course, relapse history, medication, comorbidities.
Adverse events
Deﬁned as any undesirable outcome, such as injury, falls,
discomfort, pain, relapse. These will be recorded and
reviewed by an independent Safety Monitoring Committee
(comprising a neurologist and a physiotherapist).
Balance, gait mobility
▸ Two-minute walk test99
▸ Step test100
▸ Steady stance test101
▸ Instrumented Timed Up and Go (ITUG)102
▸ Gait stride-time rhythmicity103
▸ Static posturography (Limits of Sway)104
Physical activity
▸ Godin Leisure-Time Exercise Questionnaire
(GLTEQ)105 106
▸ ActivPAL107
Hand dexterity/coordination
▸ Nine-hole peg test108
Self-efficacy
▸ The Spinal Cord Injury Exercise Self Efﬁcacy Scale
(SCI-ESES)22 109
▸ The Multiple Sclerosis Self-Efﬁcacy (MSSE) Scale110
Psychological well-being and QoL
▸ Hospital Anxiety and Depression Scale (HADS)111
▸ EuroQual 5 Dimensions-5 Levels (EQ-5D-5L)112
▸ Multiple Sclerosis Impact Scale (MSIS-29)113 114
▸ The Fatigue Symptom Inventory (FSI)115
▸ The Medical Outcomes Short-Form Survey V.2
(SF-36v2)116
Adherence
Measuring adherence is challenging117 118 and while some
have relied on the data captured by the Wii console, this
approach is problematic (eg, other family members could
use a participant’s Mii). In this study, adherence will be
deﬁned as the total number of days on which activities are
performed divided by the number of days agreed with the
physiotherapist in the action plan. We will also collect
information related to duration and intensity119 120 as well
as the data stored on the Wii console.
Process measures
▸ Daily play log (date/time, whether played, AEs (eg, pain,
tenderness, soreness, fatigue, dizziness, headaches,
aching, stiffness, falls), activity, duration, intensity,119 120
enjoyment, fatigue, reasons for non-use, free-text
comments).
▸ Physiotherapist feedback: Participant contacts will be
recorded using a template. At the end of the inter-
vention period the physiotherapists will be inter-
viewed about the ease of delivering the intervention
and any problems encountered.
▸ Semistructured interviews will be conducted (at home/
via telephone) on a purposive sample of participants
selected to represent factors pertinent to expecta-
tions/experiences of participating in the study and
receiving Mii-vitaliSe (such as age, gender, employ-
ment status, disease severity, prior experience of
home console systems). These will comprise 50% of
participants from each group at the 6-month
follow-up and at the 12-month follow-up, the ‘imme-
diate’ group only.
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Health utilisation
Economic evaluation would be an important component of
future research. We will pilot an existing measure of health-
care utilisation developed for a RCT of a fatigue manage-
ment programme.93 We will provide participants with a
resource use log to aid completion of the questionnaire.
Mii-vitaliSe intervention
Drawing upon a literature review, existing materials121–125
and our knowledge of best practice in physiotherapy and
psychological interventions in MS, guidance and resource
materials for using the Wii were developed. The research
team worked in partnership with a service user panel (8
patients from the Dorset MS Service with experience of
using the Wii and familiarity with the Wii Sports and Wii Fit
Plus software). A workshop was held to discuss the
Mii-vitaliSe intervention. The following aspects were
discussed:
1. Safety aspects, patterns of usage, beneﬁts/drawbacks,
problems identiﬁed and whether/how they could be
overcome.
2. Factors contributing to longer term use.
3. Feedback about the Wii Sports and Wii Fit Plus
software.
4. Which outcome domains are most relevant/meaning-
ful to service users.
5. Feedback on the format and content of a draft daily
play log.
After an iterative process of revision, LF and ST pro-
duced a set of materials to be used as part of a
physiotherapist-supported home-based Wii intervention
(Mii-vitaliSe). These include:
▸ General information about the Wii and Mii-vitaliSe;
▸ Safety and technical information;
▸ Guidance on warm up/cool down exercises;
▸ A guidance book and personal activity workbook;
▸ Games descriptors for Wii Sports, Wii Sports Resort
and Wii Fit Plus;
▸ Tips on goal-setting and overcoming barriers;
▸ Signposts to useful resources (eg, websites, forums);
▸ Quotations from pwMS who attended the consult-
ation workshop about their experiences of using the
Wii.
The Mii-vitaliSe intervention is underpinned by princi-
ples of self-management, social cognitive, motivational
interviewing and cognitive behavioural theories. It incor-
porates a workbook to enable individually tailored goal
setting, monitoring and the identiﬁcation of facilitators
and barriers to engagement with Mii-vitaliSe.
Usual care
The Dorset MS service offers pwMS multidisciplinary
support. Patients are reviewed annually by the team at
an outpatient clinic or home visit appointment. This
includes a medical review by a neurologist and specialist
MS nurse and a therapy review by a physiotherapist and
occupational therapist. On completion of the review and
necessary assessments, medical and therapy treatment is
modiﬁed as required. If patients experience a deterior-
ation of their symptoms before the next review they can
self-refer to the service. This may take the form of
advice regarding relapse management or speciﬁc
intervention.
The team operates a help-line between 9:00 and 11:00
Monday to Friday and there is an answer-phone out of
hours. The team is available to discuss problems with
patients and action appropriate treatments in a timely
way. If therapy is required (occupational therapy/physio-
therapy) this is offered by the MS specialist therapists
and patients can be assessed and treated at home, as an
outpatient, in work or a gym environment. Education,
support and advice regarding disease modifying therap-
ies, management of symptoms and carer support is avail-
able from the specialist nurse.
Statistical analysis
Recruitment and retention rates for the study and SDs
of potential primary outcome measures will be
Mii-vitaliSe intervention
Session 1: Orientation to the Wii in the hospital setting (week 1)
The physiotherapist goes through the guidance book with the par-
ticipant to cover:
▸ The benefits of physical activity
▸ A practical demonstration of using the software (Wii Sports,
Wii Sports Resort and Wii Fit Plus) safely
▸ Creating a ‘Mii’
▸ Familiarisation with the controls
Session 2: Training and individualised assessment in the hospital
setting (week 2)
Participants will be guided through warm up/cool down exercises
and given the opportunity to try out activities safely under super-
vision. The physiotherapist and participant will discuss appropri-
ate activities, taking into account physical capabilities, and
personal preferences.
Session 3: Installation of Wii at home and starting individual pro-
gramme (week 3)
The physiotherapist will install the Wii equipment in participants’
homes to interface with their television. Participants will be pro-
vided with Wii Sports, Wii Sports Resort and Wii Fit Plus, asked
to use their Mii when playing, and to log any other software used
via the daily play log. The physiotherapist will reiterate safety
advice (eg, the importance of the safety strap, taking a graded
approach and frequent rests, etc). The physiotherapist will agree
an individualised programme with the participant, indicate ways
this could be progressed and provide guidance on keeping the
daily play log and on setting/recording goals.
Ongoing support and monitoring
This will be followed by independent home use supported by a
combination of telephone support (week 5—to identify and
resolve any early difficulties encountered; week 12 to encourage
progress, support people to overcome any barriers) and home
review visits (weeks 7 and 16) at which the physiotherapist will
reassess the individual and provide support and discuss possible
progression/modification of the activities. Thereafter, ongoing
monitoring, support and encouragement will be provided via
monthly contact (phone/email) from the physiotherapist.
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estimated, and precision summarised using 95% CIs. For
each individual, adherence will be summarised ((the
number of days on which activities were performed
divided by the number of days recommended by the
physiotherapist)×100%). These data will be collected via
participant-completed daily play logs. We will estimate
mean adherence (%) in the ﬁrst 6 months of using the
Wii by combining data from months 1–6 for the immedi-
ate group and months 7–12 for the delayed group. We
will estimate adherence in the second 6 months of using
the Wii using data from months 7–12 in the immediate
Wii group.
We will develop and test out data analysis procedures
in preparation for developing a statistical analysis plan
for a later RCT. This will involve (1) capitalising on the
randomised nature of the study by comparing outcomes
between study arms at 6 months (in months 1–6 the
immediate Wii group will have been using the Wii, and
the delayed group will not have been using the Wii), (2)
analysing within person change over 6 months of using
the Wii (ie, months 1–6 in the immediate group and
months 7–12 in the delayed group) and (3) analysing
within person change over 12 months of using the Wii
(ie, months 1–12 in the immediate group).
Qualitative analysis
The interviews will be recorded, transcribed and thematic-
ally analysed using a generic qualitative approach126–131
and involving inter-researcher and service user interpret-
ation/discussion. Free-text comments in the daily play logs
will be collated and summarised. Themes developed will
inform the design of a future trial and the selection of
outcome measures.
Participant withdrawal from study and/or from research
follow-up
If a participant withdraws from the study, the study
researcher will be informed and will contact the partici-
pant. Provided the participant is willing to give a reason,
the study researcher will ﬁnd out why he/she wishes to
withdraw from the study. The study researcher will also
determine whether he/she wishes to continue to be
included in the research follow-up or wishes to withdraw.
If the participant wishes to withdraw from the research
follow-up the study researcher will determine whether
he/she gives permission to retain data collected before
withdrawal for use at ﬁnal analysis, or whether this infor-
mation should be destroyed. No data will be used in the
analysis without a participant’s consent.
Adverse events
All AEs and their possible relation to the Mii-vitaliSe
intervention will be closely monitored, documented and
reported to the study Safety Monitoring Committee. The
Safety Monitoring Committee will consider the events
and offer advice to the project team. Participants will be
asked to report all AEs related to use of the Wii to either
the physiotherapists delivering Mii-vitaliSe or to the study
researcher. These will be recorded on a case report form.
In addition there will be a section on the daily play log to
record AEs (including pain, tenderness, soreness,
fatigue, dizziness, headaches, aching, stiffness, nausea,
falls or near falls). The physiotherapists will ask partici-
pants whether they have experienced any AEs related to
using the Wii in their monthly monitoring phone calls.
The Dorset Multiple Sclerosis team will notify the
research team of any AEs that become known to them.
The Chief Investigator will assess an AE to establish if
it should be classiﬁed as a Serious Adverse Event (SAE)
according to the National Research Ethics Service deﬁn-
ition. If the AE is not deﬁned as ‘serious’, it will be
recorded in the study site ﬁle and the participant will be
followed up by the research team. The AE will be docu-
mented in a participant’s MS Service notes (where
appropriate). Reports of related and unexpected SAEs
will be submitted to the Research Ethics Committee
within 15 days of the CI becoming aware of the event,
using the ‘Report of SAE form for non-CTIMPs’ (V.3,
April 2007), published on the NRES website. The
sponsor will be notiﬁed within 24 h.
Project management and safety monitoring
The study researcher will deal with the day-to-day manage-
ment and coordination of the study and will call on other
members of the project team as appropriate. The Chief
Investigator will be responsible for the overall management
of the project. The CI, study statistician, and study
researcher will have regular meetings to discuss study pro-
gress. The study steering group will meet twice yearly to
monitor progress. A Safety Monitoring Committee compris-
ing two independent advisors (a neurologist with expertise
in MS and clinical trials and a physiotherapist with expertise
in risk assessment and management of service users with
neurological disability) will review any AEs and make
recommendations to the study steering group (eg, adapting
the protocol/stopping the study, as necessary).
Monitoring and audit
The study will be monitored and audited in accordance
with Poole Hospital NHS Foundation Trust (PHFT)
policy. All trial related documents will be made available
on request for monitoring and audit by PHFT and the
Research Ethics Committee. Regular meetings will take
place with the study monitor.
Ethical considerations and dissemination
The study has been reviewed and given a favourable
opinion by the National Health Service (NHS) South
Central Hampshire B Research Ethics Committee (ref:
12/SC/0420). Poole Hospital NHS Foundation Trust is
acting as the sponsor. The study will be performed
subject to Research Ethics Committee (REC) approval,
including any provisions of Site Speciﬁc Assessment
(SSA), and local Research and Development (R&D)
approval. This study will be conducted in accordance
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with the Research Governance Framework for Health
and Social Care and GCP.
It is likely that majority of the participants in the study
will have fatigue, and so we will try to minimise the
impact that participation in the study has on their
fatigue (eg, by staggering questionnaire load and provid-
ing a refreshment break during the physical assessments,
offering taxi transport to the hospital).
We aim to disseminate the results of this research
working closely with service user partners and the
funder. It is anticipated that at least one publication in a
peer reviewed journal will be produced and we intend
to present the ﬁndings at a national and international
conference. In collaboration with our service users we
will produce a short report suitable for the general
public. Further dissemination to pwMS will be via our
unit’s website, the Wiihabilitation website and (with
their permission) MS charities and the Chartered
Society of Physiotherapy. We also plan to disseminate
ﬁndings via press releases and social media.
DISCUSSION
This pilot study will assess the acceptability and suitability of
a home-based physiotherapist supported Wii intervention
(Mii-vitaliSe) to increase activity levels in pwMS. Mii-vitaliSe
addresses limitations highlighted in the literature by incorp-
orating home-based activity, behavioural change principles,
employing mixed methods and including a long term
follow-up period. Findings from this study will establish
whether a full scale RCT is feasible and, if supportive of pro-
ceeding to a full trial, will inform its design and conduct.
The decision on whether to progress to a full trial will be
made by the trial steering group. No speciﬁc criteria have
been set. If found to be effective in a full trial, Mii-vitaliSe
could increase activity levels in a group of people known to
have low activity levels overall and could be readily imple-
mented in a healthcare system such as the NHS.
Technological developments in this ﬁeld are ongoing with
rehabilitation software currently being developed for the
Nintendo Wii and other platforms. The general principles
and ﬁndings from this research will have relevance for the
next generation of software and platforms and also for
other chronic conditions.71 87
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